Ticker

No recent analyst price targets found for SSUMY.

Latest News for SSUMY

Sumitomo Pharma America Announces First Patient Receives Treatment in Phase 1/2a Study for its Investigational Therapy DSP-3077 for Retinitis Pigmentosa

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sumitomo Pharma America, Inc. (SMPA) today announced that the first patient in its study evaluating DSP-3077 in the treatment of non-syndromic retinitis pigmentosa (RP) has undergone subretinal implantation. DSP-3077 is an investigative regenerative cell therapy that leverages allogeneic retinal sheets derived from induced pluripotent stem (iPS) cells. This Phase 1/2a,…

Business Wire • Aug 12, 2026
SSUMY or HON: Which Is the Better Value Stock Right Now?

Investors interested in Diversified Operations stocks are likely familiar with Sumitomo Corp. (SSUMY) and Honeywell International Inc. (HON). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Jul 21, 2026
Are Investors Undervaluing Sumitomo (SSUMY) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • Jul 21, 2026
SSUMY or HON: Which Is the Better Value Stock Right Now?

Investors interested in Diversified Operations stocks are likely familiar with Sumitomo Corp. (SSUMY) and Honeywell International Inc. (HON). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Jun 29, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for SSUMY.

No Senate trades found for SSUMY.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top